Overview
Jeffrey Brennan said it was significant that the FTC imposed a disgorgement penalty on a major pharmaceutical maker to settle so-called “pay-for-delay” allegations, because the five FTC commissioners have been somewhat split along party lines on when to use disgorgement in recent years. Read the full article